R TPR 013
Alternative Names: R-TPR-013Latest Information Update: 14 May 2015
At a glance
- Originator Reliance Life Sciences
- Class Infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Female infertility
Most Recent Events
- 07 Feb 2011 Reliance Life Sciences completes a phase III trial in Female infertility in India